Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer
Diseases of the Esophagus, 08/20/08
Cho SH et al. - In a trial to evaluate the efficacy and safety of concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer, it was shown that the main hematological toxicity was neutropenia, but no neutropenic fever was observed. The major non-hematological toxicities were asthenia and vomiting, mostly of grades 1 and 2. Concurrent chemoradiotherapy with S-1 and cisplatin may be a promising nonsurgical treatment in advanced esophageal cancer
Methods- Pts with locally advanced or metastatic squamous cell carcinoma of the esophagus received S-1 and cisplatin at doses of 70 mg/m2/day for 14 days and 70 mg/m2 on day 1, respectively, every 3 weeks
- Concurrently, radiotherapy was started at a dose of 200 cGy/day, up to a total of 5400 cGy
- After concurrent chemoradiotherapy, additive chemotherapy was repeated up to 6 cycles
- 30 pts were enrolled; of the 27 in whom efficacy could be evaluated, an objective response rate was seen in 20, including 5 complete pathologic responses in primary lesions
- Improvement of dysphagia was seen in 21 pts
- In pts with stage II or III esophageal cancer, median progression-free survival and overall survival were 10.6 months, respectively
- In pts with stage IV esophageal cancer, median progression-free survival and overall survival were 5.4 months and 11.6 months, respectively
| Previous Article | Next Article |
Today in Esophagus...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic Criteria for Eosinophilic Esophagitis: A 5-year Retrospective Review in a Pediatric Population
Journal of Pediatric Gastroenterology and Nutrition, 06/29/09
Endoscopic submucosal dissection with a combination of small-caliber-tip transparent hood and flex knife is a safe and effective treatment for superficial esophageal neoplasias
Surgical Endoscopy, 06/15/09
Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases
Annals of Thoracic Surgery, 07/01/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management
Annals of Surgical Oncology, 06/12/09
Evolving treatment strategies for gallbladder cancer
Annals of Surgical Oncology, 06/08/09
Surgical management of gastrointestinal stromal tumours
British Journal of Surgery, 06/19/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of Racecadotril as Outpatient Treatment for Acute Gastroenteritis: A Prospective, Randomized, Parallel Stud
The Journal of Pediatrics, 06/30/09
Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors
European Journal of Surgical Oncology, 06/03/09
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Journal of Infection, 06/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


